Company news
Renalytix Plc (LSE:RENX) news
Renalytix Plc news releases on 6ix. Latest, Jan 17, 2025: Foreign Private Issuer re-qualification
Press releases — page 2
Foreign Private Issuer re-qualification
January 17, 2025
Grant & Cancellation of Options
December 30, 2024
Director/PDMR share purchase
December 20, 2024
AGM Statement
December 19, 2024
Director/PDMR dealings
December 11, 2024
Directorate Change
December 2, 2024
Publication of Annual Report and Notice of AGM
November 26, 2024
Audited Full Year Fiscal 2024 Results
November 21, 2024
Financial Results for Q1 of Fiscal Year 2025
November 20, 2024
Cancellation of Ordinary Shares & TVR
November 6, 2024
Result of General Meeting
October 31, 2024
Posting of Circular & Notice of GM
October 11, 2024
Admission of Shares & Total Voting Rights
October 8, 2024
Result of Placing and Subscription
October 1, 2024
Placing and Subscription
September 30, 2024
Change of Adviser
August 30, 2024
Nasdaq Grants Listing Extension
August 27, 2024
Appointment of Joint Corporate Broker
August 21, 2024
Termination of Formal Sale Process
August 20, 2024
Total Voting Rights
July 30, 2024
Issue of Shares and Rule 2.9 Announcement
July 15, 2024
Steno Diabetes Center (Copenhagen) Collaboration
July 11, 2024
Admission of the Second Tranche Placing Shares
July 1, 2024
Nasdaq Delisting Determination - Appeal update
June 28, 2024
Change of public accounting firm
June 25, 2024
Medicare issues final Local Coverage Determination
June 14, 2024
PDMR Dealing
June 13, 2024
Management Change
May 28, 2024
Block Admission & “At The Market” Sales Agreement
May 21, 2024
Renalytix Reports Financial Results for Q3 FY2024
May 15, 2024
Notice of Q3 Results
May 9, 2024
Admission of the First Tranche Placing Shares
April 29, 2024
Allotment and issue of Second Tranche Shares
April 25, 2024
Rule 2.9 Announcement
April 16, 2024
Completion of Financing and Total Voting Rights
April 15, 2024
Issue of Shares
April 10, 2024
Financing with Expected Size of up to $4 Million
April 8, 2024
Change of Registered Address
April 5, 2024
Notice of GM
April 3, 2024
Rule 2.9 announcement
March 15, 2024
KidneyIntelX™ included in KDIGO 2024 Guideline
March 14, 2024
Successful completion of upsized $12m placing
March 12, 2024
Approach from Possible Strategic Acquiror
March 4, 2024
Grant of Share Options - replacement
March 1, 2024
US Government coverage expanded
February 29, 2024
Half Year Report
February 15, 2024
Renalytix to Participate in the BTIG Conference
February 9, 2024
Update on kidneyIntelX.dkd LCD Consideration
January 17, 2024
New published data for KidneyIntelX™
January 10, 2024
Grant of Share Options
November 23, 2023